Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

IL9 Receptor anticorps (Extracellular Domain)

Cet anticorps anti-IL9 Receptor est un anticorps Souris Monoclonal détectant IL9 Receptor dans ELISA, FACS, Func et Neut. Adapté pour Humain.
N° du produit ABIN327384

Aperçu rapide pour IL9 Receptor anticorps (Extracellular Domain) (ABIN327384)

Antigène

Voir toutes IL9 Receptor (IL9R) Anticorps
IL9 Receptor (IL9R) (Interleukin 9 Receptor (IL9R))

Reactivité

  • 43
  • 20
  • 2
Humain

Hôte

  • 33
  • 13
  • 2
Souris

Clonalité

  • 31
  • 16
  • 1
Monoclonal

Conjugué

  • 31
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp IL9 Receptor est non-conjugé

Application

  • 26
  • 25
  • 22
  • 11
  • 6
  • 4
  • 4
  • 3
  • 3
  • 3
  • 1
  • 1
ELISA, Flow Cytometry (FACS), Functional Studies (Func), Neutralization (Neut)
  • Épitope

    • 7
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Extracellular Domain

    Specificité

    Recognizes human IL-9R. In direct ELISAs, this antibody does not cross-react with rhIL-4 R, rhIL-5 R, rhIL-5 R, rhIL-13 R 1, rhIL-13 R 2, or rmIL-9 R.

    Purification

    Protein G purified

    Immunogène

    Sf21-derived rhIL-9 R extracellular domain.

    Type of Immunogen: Recombinant protein

    Isotype

    IgG1
  • Indications d'application

    Approved: ELISA, Flo, Func, Neut

    Usage: Neutralization of bioactivity, Flow Cytometry, Direct ELISA. Neutralization of Human IL-9 Receptor-mediated bioactivity: The exact concentration of antibody required to neutralize the human cell surface IL-9 R mediated bioactivity is dependent on the IL-2 concentration as well as on the number and types of IL-2 receptors present on the cell surface (a function of cell type and culture conditions). The Neutralization Dose50 (ND50) for this antibody is defined as that concentration of antibody required to yield one-half maximal inhibition of the cell surface IL-9 R mediated IL-9 response on a responsive cell line, at a specific IL-9 concentration. The ND50 for this lot of anti-human IL-9 R antibody was determined to be approximately 2-4 μg/mL for inhibiting the IL-9-dependent proliferation of MO7e cells (1 x 10^5 cells/mL) in the presence of 2 ng/mL of rhIL-9. Flow Cytometry: This antibody was validated for flow cytometry using blood-derived monocytes. Dilute this antibody to 50 μg/mL and add 10 μL of the diluted solution to 1-2.5 x 10^5 cells in a total reaction volume not exceeding 200 μL. The binding of unlabeled antibodies may be visualized by adding a secondary developing reagent such as anti-mouse IgG conjugated to a fluorochrome. Direct ELISA: This antibody can be used at 0.5-1.0 μg/mL with the appropriate secondary reagents to detect human IL-9 R. The detection limit for rhIL-9 R is approximately 6 ng/well.

    Commentaires

    Target Species of Antibody: Human

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Reconstitution: Reconstitute, sterile PBS. If 1 mL of PBS is used, the antibody concentration will be 500 μg/mL.

    Concentration

    Lot specific

    Buffer

    Lyophilized from PBS, 5 % trehalose. Reconstitution: Reconstitute, sterile PBS. If 1 mL of PBS is used, the antibody concentration will be 500 μg/mL.
  • Antigène

    IL9 Receptor (IL9R) (Interleukin 9 Receptor (IL9R))

    Autre désignation

    IL9R / CD129

    Sujet

    Name/Gene ID: IL9R
    Family: Interleukin

    Synonyms: IL9R, IL-9 receptor, IL-9R, Interleukin 9 receptor, Interleukin-9 receptor, CD129, CD129 antigen

    ID gène

    3581

    UniProt

    Q01113

    Pathways

    Signalistation JAK/STAT, Growth Factor Binding
Vous êtes ici:
Chat with us!